The global blood collection devices market is projected to grow from USD 9.13 billion in 2025 to USD 13.02 billion by 2030, registering a CAGR of 7.4% during the forecast period. This growth reflects the increasing importance of blood-based diagnostics across healthcare systems worldwide, driven by the rising burden of chronic diseases, infectious outbreaks, surgical procedures, and expanding blood donation programmes.
Blood collection is a foundational step in modern healthcare. Whether for routine diagnostic testing, disease monitoring, transfusion medicine, or therapeutic procedures, the quality and safety of blood collection directly influence clinical outcomes. As healthcare providers seek to improve patient experience, reduce contamination risks, and increase laboratory efficiency, demand for advanced blood collection technologies is accelerating.
Why Blood Collection Devices Matter More Than Ever
Blood collection devices include blood collection tubes, needles, syringes, lancets, blood bags, apheresis systems, and capillary blood collection systems used in hospitals, diagnostic laboratories, blood banks, ambulatory surgical centres, and home healthcare settings.
The market is expanding because blood testing remains one of the most frequently performed medical procedures globally. Increasing screening programmes for diabetes, cardiovascular diseases, cancer, liver disorders, and infectious diseases require repeated blood sampling, creating sustained demand for reliable collection products.
In addition, healthcare systems are placing greater emphasis on:
- Patient safety and infection prevention
- Needlestick injury reduction
- Sample integrity for automated laboratory workflows
- Point-of-care and decentralised diagnostics
- Minimally invasive blood sampling techniques
These trends are transforming blood collection from a routine consumables segment into a technology-driven market focused on efficiency, safety, and accessibility.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117
Key Growth Drivers
Rising prevalence of chronic and lifestyle-related diseases
The global increase in diabetes, obesity, hypertension, and cardiovascular diseases has significantly increased the volume of diagnostic blood tests performed each year. Patients with chronic conditions often require frequent monitoring of biomarkers, glucose levels, lipid profiles, coagulation parameters, and therapeutic drug levels, driving recurring demand for blood collection consumables.
Expanding hospital and surgical infrastructure
Growing investments in hospitals, trauma centres, emergency departments, and surgical facilities are increasing the need for safe and efficient blood collection systems. Surgical procedures, critical care management, and trauma treatment frequently require blood typing, cross-matching, transfusion support, and continuous laboratory monitoring.
Increasing awareness of blood donation
Governments and healthcare organisations are actively promoting voluntary blood donation programmes to ensure adequate blood supplies for surgeries, cancer treatment, maternal care, and emergency medicine. This has boosted demand for blood bags, donor sets, anticoagulant systems, and apheresis technologies used in blood collection centres.
Growth of diagnostic and preventive healthcare
The shift toward preventive healthcare and early disease detection is increasing routine health check-ups and screening programmes. As diagnostic testing volumes rise, laboratories require high-quality blood collection devices that ensure accurate sample preservation and compatibility with automated analysers.
Industry Innovation Is Accelerating
Recent developments demonstrate how leading companies are investing in less-invasive sampling, automation, and advanced blood component collection technologies.
Terumo BCT strengthens innovation partnerships
In January 2025, Terumo BCT, Inc. signed a Memorandum of Understanding (MoU) with the Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection. The partnership focuses on technical research and innovation, particularly in strategic areas such as blood component collection, highlighting the industry’s focus on improving efficiency and safety in transfusion medicine.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=39733117
BD advances capillary blood collection
In December 2024, Becton, Dickinson and Company (BD) and Babson Diagnostics launched the BD MiniDraw Capillary Blood Collection System. The system enables laboratory-quality testing using as few as six drops of blood collected from a fingerstick, representing a significant step toward patient-friendly, minimally invasive diagnostics.
This innovation is particularly important for:
- Paediatric testing
- Elderly patients
- Point-of-care settings
- Retail pharmacies and community healthcare
- Remote and home-based diagnostics
The success of such technologies could reshape traditional venous blood collection workflows over the next decade.
Competitive Landscape
The blood collection devices market is moderately consolidated, with several multinational companies competing through product innovation, global distribution networks, strategic partnerships, acquisitions, and manufacturing expansion.
Major participants include:
- Fresenius Kabi AG (Germany)
- Becton, Dickinson and Company (US)
- Terumo BCT, Inc. (Japan)
- Grifols, S.A. (Spain)
- Nipro Medical Corporation (Japan)
- SARSTEDT AG & Co. KG (Germany)
- Haemonetics Corporation (US)
- Greiner Bio-One (Austria)
- ICU Medical, Inc. (US)
Between January 2022 and August 2025, these companies actively pursued partnerships, collaborations, agreements, mergers, acquisitions, expansions, and product launches to strengthen their market positions.
Company Spotlight: Fresenius Kabi AG
Fresenius Kabi AG is currently the largest player in the global blood collection devices market. The company has built a strong reputation in blood bags and related consumables, supported by:
- A broad product portfolio
- Strong customer satisfaction
- Extensive global distribution capabilities
- High brand recognition in transfusion medicine
Fresenius is increasingly focusing on automation and sustainability initiatives in manufacturing while expanding its presence in Asia Pacific and Latin America, where healthcare infrastructure and blood donation programmes are growing rapidly.
Its ability to combine manufacturing scale, product reliability, and geographic expansion has helped maintain its leadership position.
Company Spotlight: Becton, Dickinson and Company (BD)
BD holds the second-largest share of the market and offers one of the industry’s most comprehensive portfolios, including:
- Blood collection tubes
- Needles
- Syringes
- Blood bag sets
- Lancets
- Capillary collection systems
The company’s Vacutainer franchise remains a global benchmark for venous blood collection. BD is now expanding aggressively into capillary and fingerstick-based diagnostics, reflecting the broader trend toward decentralised healthcare and improved patient comfort.
Key strategic priorities include:
- Less-invasive sampling
- Point-of-care testing
- Digital health integration
- Expansion in high-growth Asia Pacific markets
BD’s strong presence in North America and Europe provides a solid foundation for global expansion.
Company Spotlight: Terumo BCT, Inc.
Terumo BCT is recognised as a technology leader in blood component collection and apheresis systems. The company has developed advanced platforms that support:
- Platelet collection
- Plasma collection
- Red blood cell separation
- Automated blood component processing
In 2024, Terumo launched the Intercept 10 Platelet System, designed to improve plateletpheresis efficiency and safety. The company has also expanded manufacturing operations in the United States and Costa Rica to strengthen supply chain resilience.
Terumo’s investments in digital blood management platforms and cell-based therapy applications position it beyond traditional blood collection, creating opportunities in advanced therapeutics and regenerative medicine.
Market Ranking: The Leading Five Players
The current top five companies are:
- Fresenius Kabi AG
- Becton, Dickinson and Company
- Terumo BCT, Inc.
- Greiner Bio-One
- Cardinal Health
These companies lead through a combination of:
- Comprehensive product portfolios
- Global distribution infrastructure
- Safety-engineered technologies
- Automation compatibility
- Strong customer support networks
Greiner Bio-One
Greiner Bio-One’s VACUETTE products are widely recognised for sample integrity, reliable vacuum performance, and compatibility with automated laboratory analysers, making the company a strong player in the diagnostic laboratory segment.
Cardinal Health
Cardinal Health leverages its extensive medical supply distribution network to provide blood collection products alongside broader hospital and laboratory procurement solutions, strengthening its competitive position through service integration and logistical reach.
Emerging Trends Shaping the Future
Capillary blood collection and microsampling
Fingerstick-based collection systems are gaining momentum because they:
- Reduce patient discomfort
- Require smaller blood volumes
- Enable testing outside traditional laboratory settings
- Support telehealth and home diagnostics
This trend could significantly expand testing access in rural, remote, and resource-limited environments.
Automation and smart sample management
Laboratories are increasingly adopting automated pre-analytical systems that require standardised blood collection tubes and traceable sample handling. Manufacturers are responding with products designed for:
- Automated centrifugation
- Robotic sample sorting
- Barcode and RFID tracking
- Digital chain-of-custody integration
Safety-engineered devices
Healthcare worker safety remains a major priority. Demand for retractable needles, shielded collection devices, and closed-system blood collection technologies is expected to grow as regulatory agencies continue to strengthen occupational safety requirements.
Sustainability initiatives
Hospitals and blood banks are under pressure to reduce plastic waste and environmental impact. Leading manufacturers are exploring:
- Recyclable materials
- Reduced packaging
- Energy-efficient manufacturing processes
- Sustainable supply chain practices
Regional Growth Opportunities
North America
North America remains the largest market, supported by:
- High diagnostic testing volumes
- Advanced healthcare infrastructure
- Strong reimbursement systems
- Rapid adoption of innovative collection technologies
Europe
Europe benefits from well-established blood donation networks, transfusion safety regulations, and laboratory automation adoption, supporting steady market growth.
Asia Pacific
Asia Pacific is expected to be the fastest-growing region due to:
- Expanding healthcare infrastructure
- Rising healthcare expenditure
- Increasing chronic disease prevalence
- Government-led blood donation initiatives
- Growing diagnostic laboratory networks
Countries such as China, India, Indonesia, and Vietnam represent significant long-term growth opportunities for global manufacturers.
Strategic Outlook for Industry Stakeholders
For manufacturers, the most attractive opportunities lie in:
- Capillary and microsampling technologies
- Automated blood collection workflows
- Integrated digital sample management
- Emerging market expansion
- Sustainable product innovation
For healthcare providers and laboratory operators, future procurement decisions will increasingly prioritise:
- Patient comfort
- Sample quality
- Workflow efficiency
- Safety compliance
- Compatibility with automated diagnostic systems
Companies that can deliver high-quality consumables while integrating automation, digital traceability, and minimally invasive sampling capabilities will be best positioned to capture market share.
Conclusion
The global blood collection devices market is entering a new phase of growth, driven by the convergence of rising diagnostic demand, chronic disease monitoring, transfusion medicine expansion, and patient-centric innovation. With the market expected to reach USD 13.02 billion by 2030, blood collection is evolving from a routine clinical procedure into a strategically important component of modern healthcare delivery.
Industry leaders such as Fresenius Kabi, BD, and Terumo BCT are shaping the competitive landscape through automation, advanced component collection systems, and less-invasive capillary sampling technologies. At the same time, emerging trends in digital integration, safety-engineered devices, and sustainable manufacturing are redefining customer expectations across hospitals, laboratories, and blood banks.
As healthcare systems worldwide continue to expand access to diagnostics, preventive screening, and transfusion services, demand for safer, smarter, and more efficient blood collection solutions will remain strong, making this market an important area of opportunity for manufacturers, healthcare providers, and investors through 2030 and beyond.
For more information, Inquire Now!